During the corresponding time, Mesa Laboratories Inc recorded a revenue increase by 2.03 % year on year, sequentially revenue fell by -6.33 %. While revenue at the Mesa Laboratories Inc's corporate clients
Mesa Laboratories Inc's Comment on Sales, Marketing and Customers
The company operates manufacturing facilities in the United States and Europe and markets its products in North America, Europe, and the Asia Pacific region, as well as through independent distributors worldwide. Its products and services aim to protect vulnerable populations by ensuring product integrity, enhancing patient and worker safety, and improving quality of life. Revenue is generated from sales of consumables, hardware, and maintenance, calibration, and testing services. The company serves the life sciences tools and critical quality control solutions markets for regulated applications and employs a customer-centric approach supported by its Mesa Way system for continuous improvement.
Mesa Laboratories Declares Quarterly Dividend, Reflects Commitment to Shareholder Value LAKEWOOD, Colo. April 7, 2025 Mesa Laboratories, Inc. (NASDAQ: MLAB) has announced its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. This dividend is set to be paid on June 16, 2025, to shareholders who are on record as of the close of business on May 30, 2025. The decision to issue a dividend underscores Mesa Labs ongoing commitment to returning value to its shareholders amidst a backdrop of steady performance. With 5.429 million shares outstanding, and a current stock price hovering around $108, this move is likely to enhance shareholder confidence and attract pote...
Mesa Laboratories, Inc. Revises Earnings Announcement and Releases Second Annual Responsible Business Program BrochureMesa Laboratories, Inc., a global leader in life science tools and critical quality control solutions, has recently announced two significant updates. The company has revised the earnings announcement date for its unaudited fourth quarter and full fiscal year 2024 results to May 31, 2024. Additionally, Mesa Labs has released its second annual Environmental, Social, and Governance (ESG) Program Brochure, showcasing its commitment to environmental stewardship, social responsibility, and corporate governance.The delayed earnings announcement is primarily due to the company s ongoing efforts to f...
Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024LAKEWOOD, Colo., April 01, 2024 - Mesa Laboratories, Inc., a leading global provider of critical quality control solutions for various industries, including pharmaceuticals, medical devices, and food and beverage, has announced that it will be releasing its financial results for the fourth quarter and full fiscal year ending March 31, 2024. The press release is scheduled to be issued at 8:00 A.M. Eastern time on Friday, May 24, 2024. This much-anticipated announcement will shed light on the company s performance during a crucial period and provide insights into its growth and future prospects.Mesa La...
Mesa Laboratories Inc’s Comment on Sales, Marketing and Customers
The company operates manufacturing facilities in the United States and Europe and markets its products in North America, Europe, and the Asia Pacific region, as well as through independent distributors worldwide. Its products and services aim to protect vulnerable populations by ensuring product integrity, enhancing patient and worker safety, and improving quality of life. Revenue is generated from sales of consumables, hardware, and maintenance, calibration, and testing services. The company serves the life sciences tools and critical quality control solutions markets for regulated applications and employs a customer-centric approach supported by its Mesa Way system for continuous improvement.
Sources:
Mesa Laboratories Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Mesa Laboratories Inc’s corporate clients.
For your research, we’ve provided 9 tables on Mesa Laboratories Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
40.75 %